Clinical Trials | April 16, 2024
Suven Life Sciences to present phase-2 results on Samelisant at AAN 2024
Global Phase-3 study initiation expected in the second half of 2024
Global Phase-3 study initiation expected in the second half of 2024
The period from 2020 to 2022 witnessed a remarkable surge in deal worth
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
KarXT, Karuna’s lead asset, is a potential first-in-class treatment for Schizophrenia
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
Dexamethasone is used to treat conditions such as arthritis, blood/hormone disorders, allergic reactions
Subscribe To Our Newsletter & Stay Updated
